Small Diagnostic Chains
Market Cap
₹14,049 ₹14,049 Cr.
P/E
74.93
PEG
4.96
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis lives on replicating the integrated B2C hub-spoke model outside Hyderabad; Bangalore and West Bengal are the highest-upside engines, scaling from a tiny base to nearly a quarter of FY31 revenue.

Bull case triggers are hub breakevens sustained at 2–3 quarters (as in Yelahanka) and a potential inorganic acquisition adding ₹100–150 Cr revenue, pulling forward the diversification story.

Bear case hinges on Hyderabad growth decelerating below 10% concurrently with breakevens in new clusters stretching beyond 15 months — compounding concentration risk and execution uncertainty.

Get your Reports on Demand
Get detailed, analyst-grade reports with actionable insights to make informed investment decisions.
  Flat 20% OFF
 for Tijori Premium Users
  Flat 20% OFF  for Tijori Premium Users
5Y Revenue & EBITDA Estimates
KEY TRIGGERS TO WATCH
  • The thesis lives on replicating the integrated B2C hub-spoke model outside Hyderabad; Bangalore and West Bengal are the highest-upside engines, scaling from a tiny base to nearly a quarter of FY31 revenue.
  • Bull case triggers are hub breakevens sustained at 2–3 quarters (as in Yelahanka) and a potential inorganic acquisition adding ₹100–150 Cr revenue, pulling forward the diversification story.
  • Bear case hinges on Hyderabad growth decelerating below 10% concurrently with breakevens in new clusters stretching beyond 15 months — compounding concentration risk and execution uncertainty.
Bear : 8.7% CAGR • ₹511 Cr
Base: 15.0% CAGR • ₹679 Cr
Bull: 19.9% CAGR • ₹837 Cr
Buy Report $5
Management Credibility Report
TRACK RECORD
  • Management consistently guides conservatively and over-delivers on revenue growth and margins, building trust that guided figures represent floors, not ceilings.
  • The sole credibility gap is Pune, where post-acquisition integration took 1–1.5 years longer than anticipated, causing the revenue doubling target to be missed — management has since acknowledged the misstep.
  • The underlying pattern is systematic optimism in capex pacing and price increases, offset by a proven ability to execute ahead of core financial targets outside of M&A integration.
Met : 16
Progress: 3
Missed : 1
Buy Report $5
WORST-CASE SCENARIO
  • The forensic profile is clean, with zero debt, strong cash conversion, and unqualified audits, indicating no existential financial threats.
  • The two medium-risk items — the depreciation method switch that boosted PBT by 25% and disclosed promoter rental arrangements — are not signs of distress but warrant monitoring for earnings quality and governance.
  • The most severe external risk is a regulatory compliance audit in Telangana, where 72% revenue concentration could amplify reputational damage even from minor findings.
High Risk : 0
Medium Risk : 2
Low Risk : 15
Buy Report $5
Powered By
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material